gvtcx

Helix Biotech Biosimilar mRNA Vaccines

key details

Statuscomplete
Proceduredirect
SME suitableYes
OCIDocds-h6vhtk-059422

Awards (3)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
Helix Biotech Inc. £150,000 10 Nov 2025 pending
Helix Biotech Inc. · · active
Helix Biotech, Inc. £150,000 · cancelled

description

Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

5 notices published against this procurement.

PublishedTypeRegimeNotice
12 Aug 2025 Transparency notice (UK5) Procurement Act 2023 047894-2025
4 Sept 2025 Procurement termination (UK12) Procurement Act 2023 053927-2025
4 Sept 2025 Transparency notice (UK5) Procurement Act 2023 053931-2025
10 Nov 2025 Contract award (UK6) Procurement Act 2023 072302-2025
18 Dec 2025 Contract details (UK7) Procurement Act 2023 084284-2025

more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.